Table 1.
Parameter name | Symbol | Valuea | Source |
---|---|---|---|
Preventive circumcision program parameters | |||
Percentage of uncircumcised uninfected or uncircumcised asymptomatic HIV + males circumcised annually |
κ(t) | 0.10–0.20, t ≤ 5 0, t >5 |
Assumption |
Circumcision protective effect (percent reduction in risk of female- to-male transmission of HIV infection) |
ε | 0.61 (0–1.0) | [3] |
Change in (male-negotiated) condom use following circumcision, for males circumcised as adults following circumcision program implementation, or for males previously circumcised in childhoodb |
Δ | 1.0 (0–2.0) | Assumption |
HIV transmission parameters | |||
Male infectivity (per-partner probability of transmission to a female) | |||
Asymptomatic period of HIV infection | βM1,j | 0.0684c | [66] |
Symptomatic period of HIV infection | βM2,j | 0.1657c | [66] |
Female infectivity (per-partner probability of transmission to a male) |
|||
Asymptomatic period of HIV infection | βW1 | 0.1112c | [66] |
Symptomatic period of HIV infection | βW2 | 0.2697c | [66] |
Contact rate (number of new partners per year) of males or females | |||
Uninfected | ρ0 | 3 | [36] |
HIV infected, asymptomatic period | ρ3 | 3 | [36] |
HIV infected, symptomatic period | ρ2 | 1 | Assumption |
HIV infected, AIDS | ρ3 | 0 | Assumption |
Baseline (male-negotiated) condom use for all partnerships (without implementation of an adult male circumcision program) |
hi,,j | 0.5 | [28, 36–40] |
Condom failure rate for all partnerships | f | 0.14 | [67] |
HIV disease duration parameters | |||
Asymptomatic HIV infection (years) | 1/µ1 | 6.8 | [68–70] (with assumptions) |
Symptomatic HIV infection (years) | 1/µ2 | 2.6 | [68–70] (with assumptions) |
AIDS (years) | 1/µ3 | 0.8 | [68] |
Population parameters, heterosexual men/women >16 years | |||
Mean age (years) | 25.1 | [71] | |
Non-AIDS life expectancy (years) | 60.8 | [72] | |
Non-AIDS-related annual mortality rate | µ | 0.028d | [71, 72] |
Initial population size | 823,000 | [28, 38–40, 73] | |
Initial HIV prevalence, male population (%) | 11.6 | [38] | |
Initial HIV prevalence, female population (%) | 20.0 | [38] | |
Initial circumcision rate, baseline male population (%) | 0.35 | [27] | |
Arriving male population HIV prevalence (%) | 0.03 | [28, 38, 40, 74] | |
Arriving female population HIV prevalence (%) | 0.10 | [28, 38, 40, 74] | |
Arriving male population circumcision rate (%) | 0.35 | [28] |
Values in parentheses are ranges used in sensitivity analyses
E.g., for Δ = 1.0, no change in condom use, for Δ = 1.30, 30% increase in condom use, for Δ = 0.70, 30% decrease in condom use
See Appendix for further details
Calculated[26]